Improving Resilience And Equity In Lung Cancer Screening: Lessons From Covid-19 And Beyond | October 26-28, 2020 | Virtual Meeting

Meeting Information: October 26 - 28, 2020

This workshop was the first in the President’s Cancer Panel’s (the Panel) 2020–2021 series on cancer screening. The workshop brought together stakeholders from several sectors, including clinical care, healthcare systems, insurance companies, government agencies, research, and advocacy.

Agenda

Day 1: October 26, 2020

Day 1 Recording

Time	Agenda Item
1:00 - 1:10 p.m.	Agenda Review and Administrative Statements President’s Cancer Panel introduction, administrative remarks, agenda review
1:10 - 2:00 p.m.	Introductions and Working Group Work to Date Working Group and Stakeholder Panel introductions, planning process overview, and review of Working Group work to date
2:00 - 3:00 p.m.	Lung Cancer Screening Improvement Opportunities Session 1: Improving Screening Uptake Opportunities to improve screening, associated barriers, and possible solutions Reflect on opportunities and barriers Discuss and contribute ideas on ways to address the most significant barriers
3:00 - 3:15 p.m.	Break
3:15 - 4:15 p.m.	Lung Cancer Screening Improvement Opportunities Session 2: Health Equity Opportunities to improve screening, associated barriers, and possible solutions
4:15 - 4:35 p.m.	Working Group Review of Input and Final Comments Review of the day’s stakeholder input and reactions to day’s work
4:35 - 5:00 p.m.	Response to Public Questions and Comments

Day 2: October 28, 2020

Day 2 Recording

Time	Agenda Item
1:00 - 1:15 p.m.	Agenda Review and Administrative Statements Administrative remarks, facilitator introduces agenda and process, reflections from day 1
1:15 - 2:00 p.m.	Lung Cancer Screening Improvement Opportunities Session 3: Improving Screening Follow-Up Opportunities to improve screening, associated barriers, and possible solutions
2:00 - 2:45 p.m.	Lung Cancer Screening Improvement Opportunities Session 4: Smoking Cessation Opportunities to improve screening, associated barriers, and possible solutions
2:45 - 3:00 p.m.	Break
3:00 - 4:30 p.m.	Cross-Cutting Theme Review Review of the barriers falling into each cross-cutting theme, identification of any missing barriers Review of barriers and solutions associated with each cross-cutting theme Identification of any additional solutions Identification of the most significant barriers
4:30 - 4:40 p.m.	Working Group Review of Input and Final Comments Brief review of input and panel discussion of next steps
4:40 - 5:00 p.m.	Response to Public Questions and Comments

Participants

Name	Title & Affiliations
Otis W. Brawley, MD, MACP, FASCO, FACE	Bloomberg Distinguished Professor Department of Oncology School of Medicine Department of Epidemiology Johns Hopkins University Bloomberg School of Public Health Baltimore, MD
Melissa F. Buffalo, MS	Deputy Director American Indian Cancer Foundation Meskwaki Nation Minneapolis, MN
Lisa Carter-Harris, PhD	Associate Attending Behavioral Scientist Memorial Sloan Kettering Cancer Center New York, NY
Tanner Caverly, MD	Physician Scientist University of Michigan Medical School Ann Arbor VA Center for Clinical Management Research Ann Arbor, MI
Joseph Chin, MD, MS	Deputy Director, Coverage and Analysis Group Centers for Medicare & Medicaid Services Woodlawn, MD
Sarah Coles, MD	Chair, Subcommittee on Clinical Recommendations and Policies American Academy of Family Physicians Phoenix, AZ
Angela Criswell, MA	Associate Director Quality Screening and Program Initiatives GO2 Foundation for Lung Cancer Washington, DC
Paul Doria-Rose, PhD, DVM	Chief, Healthcare Assessment Research Branch Division of Cancer Control and Population Sciences National Cancer Institute Bethesda, MD
Chyke Doubeni, MBBS, MPH	Professor of Family Medicine Director, Center for Health Equity and Community Engagement Research Mayo Clinic Scottsdale, AZ
Joelle T. Fathi, DNP, RN, ARNP, CTTS	Associate Teaching Professor University of Washington Seattle, WA
Kathleen Fennig	Patient Advocate Clinical Research Specialist Wright State University Boomshoft School of Medicine Beavercreek, OH
Michael K. Gould, MD, MS	Professor of Health Systems Science Kaiser Permanente Bernard J. Tyson School of Medicine Pasadena, CA
Gregory K. Jenkins, MD	Physician Baptist Memorial Health Care Corporation Germantown, TN
Maureen R. Johnson, PhD	Executive Secretary, President’s Cancer Panel Special Assistant, Office of the Director National Cancer Institute National Institutes of Health Bethesda, MD
Gregory Kane, MD, MACP	Jane and Leonard Korman Professor and Chair Department of Medicine Thomas Jefferson University Hospital Philadelphia, PA
Ella A. Kazerooni, MD	Professor of Radiology and Internal Medicine University of Michigan Ann Arbor, MI
Bryan Loy, MD, MBA	Corporate Medical Director Humana Louisville, KY
Peter Mazzone, MD	Director, Lung Cancer Program Respiratory Institute Cleveland Clinic Cleveland, OH
Edith P. Mitchell, MD, MACP, FCPP	Member, President’s Cancer Panel Clinical Professor of Medicine and Medical Oncology Department of Medical Oncology Director, Center to Eliminate Health Disparities Associate Director of Diversity Affairs Sidney Kimmel Cancer Center Thomas Jefferson University Philadelphia, PA
Ronald E. Myers, PhD	Professor and Director of Population Science Thomas Jefferson University Philadelphia, PA
Wyatt Pickner, MPH	Research Manager American Indian Cancer Foundation Minneapolis, MN
Mitchell Schnall, MD, PhD	Eugene P. Pendergrass Professor of Radiology Chair, Department of Radiology University of Pennsylvania Perelman School of Medicine Philadelphia, PA
Jamie L. Studts, PhD	Professor of Medical Oncology Scientific Director of Behavioral Oncology University of Colorado School of Medicine Aurora, CO
Betty C. Tong, MD	Associate Professor of Surgery Cardiovascular and Thoracic Surgery Duke University Medical Center Durham, NC
Robert J. Volk, PhD	Professor and Deputy Department Chair Department of Health Services Research The University of Texas MD Anderson Cancer Center Houston, TX
Renda Wiener, MD, MPH	Professor of Medicine, Boston University School of Medicine Associate Director, Center for Healthcare Organization and Implementation Research VA Boston Healthcare System Newton, MA
John P. Williams, MD, FACS	Chair, President’s Cancer Panel Medical Director, Breast Cancer School for Patients Gainesville, VA
Robert Winn, MD	Director, Virginia Commonwealth University Massey Cancer Center Richmond, VA
Douglas E. Wood, MD	Henry N. Harkins Professor and Chair Department of Surgery University of Washington Seattle, WA

Summary

Participants discussed barriers and opportunities related to lung cancer screening, including those relevant to the healthcare system disruptions caused by the coronavirus disease (COVID-19) pandemic. The workshop was available to the public via live feed, and members of the public were invited to submit written comments and questions during and after the workshop. Participants were encouraged to live-Tweet at #ImprovingCancerScreening.

Meeting Outcomes

Stakeholder input on opportunities, barriers, and possible solutions to improve lung cancer screening during and post COVID-19
Stakeholder input on barriers included in cross-cutting theme areas